Synergy Hematology-Oncology Medical Associates, Inc. v. Abbott Laboratories, Inc.

District Court, C.D. California·Decided July 13, 2022·No. 2:22-cv-01560·Unknown

Opinion

Case 2:22-cv-01560-SPG-JEM Document 29 Filed 07/13/22 Page 1 of 17 Page ID #:174

CENTRAL DISTRICT OF CALIFORNIA

SYNERGY HEMATOLOGY- Case No.: 2:22-cv-01560 SPG (JEMx) ASSOCIATES, INC., a California medical corporation, STIPULATED [PROPOSED] PROTECTIVE ORDER Plaintiff, District Judge: Hon. Sherilyn P. Garnett v. Courtroom: 5C Mag. Judge: Hon. John E. ABBOTT LABORATORIES INC., a McDermott Delaware corporation, and Does 1 to 10, Courtroom: 640 inclusive, Date Filed: March 8, 2022

Defendant. DISCOVERY MATTER

ABBOTT LABORATORIES INC., a Delaware corporation, and Does 1 to 10, inclusive, Counterclaim Plaintiff, v. SYNERGY HEMATOLOGY- ASSOCIATES, INC., a California medical corporation,

Counterclaim Defendant.

{02388829} Case 2:22-cv-01560-SPG-JEM Document 29 Filed 07/13/22 Page 2 of 17 Page ID #:175

1. PURPOSES AND LIMITATIONS Discovery in this action is likely to involve the production of confidential, proprietary, or private information for which special protection from public disclosure and from use for any purpose other than pursuing this litigation may be warranted. Accordingly, the parties hereby stipulate to and petition the Court to enter the following Stipulated Protective Order. The parties acknowledge that this Order does not confer blanket protections on all disclosures or responses to discovery and that the protection it affords from public disclosure and use extends only to the limited information or items that are entitled to confidential treatment under the applicable legal principles. 2. GOOD CAUSE STATEMENT This action is likely to involve trade secrets, pricing information, and other valuable research, development, commercial, financial, technical and/or proprietary information for which special protection from public disclosure and from use for any purpose other than prosecution of this action is warranted. Such confidential and proprietary materials and information consist of, among other things, confidential business or financial information, information regarding confidential business practices, and other confidential research, development, or commercial information (including information implicating privacy rights of third parties), information otherwise generally unavailable to the public, or which may be privileged or otherwise protected from disclosure under state or federal statutes, court rules, case decisions, or common law. Accordingly, to expedite the flow of information, to facilitate the prompt resolution of disputes over confidentiality of discovery materials, to adequately protect information the parties are entitled to keep confidential, to ensure that the parties are permitted reasonably necessary uses of such material in preparation for and in the conduct of trial, to address their handling at the end of the litigation, and serve the ends of justice, a protective order for such information is justified in this {02388829} 2 2:22-cv-01560 JFW (JEMx) Case 2:22-cv-01560-SPG-JEM Document 29 Filed 07/13/22 Page 3 of 17 Page ID #:176

matter. It is the intent of the parties that information will not be designated as confidential for tactical reasons and that nothing be so designated without a good faith belief that it has been maintained in a confidential, non-public manner, and there is good cause why it should not be part of the public record of this case. The parties will be prejudiced and harmed should their confidential business, financial, research, development, and/or commercial information or trade secrets be publicly disclosed, which would allow the parties’ competitors access to such confidential information. 3. ACKNOWLEDGMENT OF FILING UNDER SEAL PROCEDURE The parties further acknowledge, as set forth in Paragraph 13.3, below, that this Stipulated Protective Order does not entitle them to file Confidential Information under seal; Local Civil Rule 79-5 and the Court’s Standing Order set forth the procedures that must be followed and the standards that will be applied when a party seeks permission from the court to file material under seal. There is a strong presumption that the public has a right of access to judicial proceedings and records in civil cases. In connection with non-dispositive motions, good cause must be shown to support a filing under seal. See Kamakana v. City and County of Honolulu, 447 F.3d 1172, 1176 (9th Cir. 2006), Phillips v. Gen. Motors Corp., 307 F.3d 1206, 1210-11 (9th Cir. 2002), Makar-Welbon v. Sony Electrics, Inc., 187 F.R.D. 576, 577 (E.D. Wis. 1999) (even stipulated protective orders require good cause showing). Further, a specific showing of good cause or compelling reasons with proper evidentiary support and legal justification must be made with respect to Protected Material that a party seeks to file under seal. The parties’ mere designation of Disclosure or Discovery Material as CONFIDENTIAL or CONFIDENTIAL – ATTORNEYS’ EYES ONLY does not—without the submission of competent evidence by declaration, establishing that the material sought to be filed under seal qualifies as confidential, privileged, or otherwise protectable—constitute good cause. {02388829} 3 2:22-cv-01560 JFW (JEMx) Case 2:22-cv-01560-SPG-JEM Document 29 Filed 07/13/22 Page 4 of 17 Page ID #:177

Further, if a party requests sealing related to a dispositive motion or trial, then compelling reasons, not only good cause, for the sealing must be shown, and the relief sought shall be narrowly tailored to serve the specific interest to be protected. See Pintos v. Pacific Creditors Ass’n., 605 F.3d 665, 677-79 (9th Cir. 2010). For each item or type of information, document, or thing sought to be filed or introduced under seal, the party seeking protection must articulate compelling reasons, supported by specific facts and legal justification, for the requested sealing order. Again, competent evidence supporting the application to file documents under seal must be provided by declaration. Any document that is not confidential, privileged, or otherwise protectable in its entirety will not be filed under seal if the confidential portions can be redacted. If documents can be redacted, then a redacted version for public viewing, omitting only the confidential, privileged, or otherwise protectable portions of the document, shall be filed. Any application that seeks to file documents under seal in their entirety should include an explanation of why redaction is not feasible. 4. DEFINITIONS 4.1 “Action”: the above-captioned federal lawsuit. 4.2 “Challenging Party”: a Party or Non-Party that challenges the designation of information or items under this Order. 4.3 “Confidential Information”: information (regardless of how it is generated, stored or maintained) or tangible things that qualify for protection under Federal Rule of Civil Procedure 26(c), and as specified above in the Good Cause Statement, which is designated as “CONFIDENTIAL” or “CONFIDENTIAL – ATTORNEYS’ EYES ONLY”. 4.4 “Counsel”: Outside Counsel of Record and In-House Counsel (as well as their support staff). {02388829} 4 2:22-cv-01560 JFW (JEMx) Case 2:22-cv-01560-SPG-JEM Document 29 Filed 07/13/22 Page 5 of 17 Page ID #:178

Free access — add to your briefcase to read the full text and ask questions with AI

Synergy Hematology-Oncology Medical Associates, Inc. v. Abbott Laboratories, Inc., (C.D. Cal. 2022).

Synergy Hematology-Oncology Medical Associates, Inc. v. Abbott Laboratories, Inc. (Synergy Hematology-Oncology Medical Associates, Inc. v. Abbott Laboratories, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Pintos v. PACIFIC CREDITORS ASS'N
605 F.3d 665 (Ninth Circuit, 2010)
Kamakana v. City and County of Honolulu
447 F.3d 1172 (Ninth Circuit, 2006)
United States v. Patrisso
20 F.R.D. 576 (S.D. New York, 1957)